Through
5/1
Health Sciences
Commonly used blood pressure meds may affect outcomes on COVID-19
Commonly used blood pressure meds may affect outcomes on COVID-19
Penn Medicine launches an international trial to study whether the medications are beneficial or harmful in the treatment of hospitalized patients.
Measuring the risk among clinicians who intubate patients with COVID-19
Measuring the risk among clinicians who intubate patients with COVID-19
Penn launches a national component of global registry to track exposures and outcomes among providers who perform airway management procedures.
Domestic violence and gun sales in the time of COVID-19
Domestic violence and gun sales in the time of COVID-19
In a Q&A, School of Social Policy & Practice researcher Susan B. Sorenson describes new challenges surrounding intimate partner violence and the uptick in gun purchases since this crisis began.
COVID-19 and lessons for public health
COVID-19 and lessons for public health
Six lessons for public health in the U.S. during the fight against COVID-19.
Penn ED tents ready for COVID-19 surge
Penn ED tents ready for COVID-19 surge
The aim of the temporary structures is to identify and sort patients before they enter the hospitals. Those with mild symptoms can get tested and sent home, leaving the space inside for more severe cases.
Tailoring treatment for triple-negative breast cancer
Tailoring treatment for triple-negative breast cancer
Research led by the School of Veterinary Medicine’s Rumela Chakrabarti identified a molecular pathway responsible for the disease’s progression and spread.
Rapid response to COVID-19 puts the power of innovation to the test
Rapid response to COVID-19 puts the power of innovation to the test
With a critical need for equipment that can help protect frontline healthcare workers, the Penn community has come together to help fabricate 20,000 face shields by mid- to late-April.
Is the U.S. winning the war against COVID-19?
Is the U.S. winning the war against COVID-19?
Ezekiel J. Emanuel, vice provost for global initiatives, gave a sobering update on how the United States is doing in the fight against COVID-19, saying the country needs to be prepared to battle the new coronavirus for about 18 months.
A cost-effective drug combination for women suffering miscarriage
A cost-effective drug combination for women suffering miscarriage
A pretreatment medication for women who suffer miscarriages called mifepristone is not only more clinically effective when combined with misoprostol, but also more cost effective
PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells
PARP inhibitor drugs can be ‘tuned’ for better killing of tumor cells
Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness
In the News
6ABC.com
Bird flu suspected in deaths of 200 snow geese in Pennsylvania’s Lehigh Valley
Stephen Cole of the School of Veterinary Medicine says that indoor cats are contracting bird flu through raw pet foods of poultry origin or raw milk products.
FULL STORY →
Self
The surgeon general calls for new warning labels on alcohol—here’s the truth about how it impacts your health
Henry Kranzler of the Perelman School of Medicine says that alcohol’s effects on the brain are observed more readily because it’s the organ of behavior.
FULL STORY →
NPR
Tuberculosis rates plunge when families living in poverty get a monthly cash payout
Aaron Richterman of the Perelman School of Medicine says that there are large and underappreciated benefits of cash-transfer programs, such as potentially ending a tuberculosis epidemic.
FULL STORY →
Time
Scientists are racing to develop a new bird flu vaccine
Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.
FULL STORY →
Newsweek
Cancer breakthrough as ‘speckles’ may reveal best treatment
A paper co-authored by PIK Professor Shelley Berger finds that patterns of “speckles” in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to treatment options.
FULL STORY →